Follow the people · Insider
Kevin Waters
Kevin Waters files insider transactions with the SEC as an evp, cfo of PROCEPT BioRobotics. We hold 4 disclosed purchases and sales filed since 30 September 2015, 1 of them in the last 90 days.
- Files for 2 companiesPRCT, ARAY
- Disclosed buys and sells4 in all, 1 in the last 90 days
- Last disclosure10 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 31 March 2022 — 9 September 2026EVP, CFO · PROCEPT BioRobotics 73 Form 4 lines · source: SEC Form 4
- Filed 30 September 2015 — 3 July 2018SVP, Chief Financial Officer · Accuray 24 Form 4 lines · source: SEC Form 4
Every transaction
97 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 9 Sep 2026 | 10 Sep 2026SEC Form 4 | 1 d | sold on the open market | PROCEPT BioRobotics | 373 shares | down −1.7% | up +1.5% |
| 13 Aug 2026 | 14 Aug 2026SEC Form 4 | 1 d | was grantednot a trade | PROCEPT BioRobotics | 29,527 shares | down −7.2% | down −5.9% |
| 13 Aug 2026 | 14 Aug 2026SEC Form 4 | 1 d | was grantednot a trade | PROCEPT BioRoboticsderivative | 40,851 shares | down −7.2% | down −5.9% |
| 8 Jun 2026 | 10 Jun 2026SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 357 shares | down −28.1% | down −29.9% |
| 17 Mar 2026 | 19 Mar 2026SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 706 shares | down −25.5% | down −20.6% |
| 17 Mar 2026 | 19 Mar 2026SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 706 shares | down −25.5% | down −20.6% |
| 6 Mar 2026 | 9 Mar 2026SEC Form 4 | 3 d | sold on the open market | PROCEPT BioRobotics | 6,721 shares | down −15.9% | down −19.3% |
| 6 Mar 2026 | 9 Mar 2026SEC Form 4 | 3 d | sold on the open market | PROCEPT BioRobotics | 6,721 shares | down −15.9% | down −19.3% |
| 5 Mar 2026 | 9 Mar 2026SEC Form 4 | 4 d | was grantednot a trade | PROCEPT BioRobotics | 47,462 shares | down −19.6% | down −19.3% |
| 5 Mar 2026 | 9 Mar 2026SEC Form 4 | 4 d | was grantednot a trade | PROCEPT BioRoboticsderivative | 32,576 shares | down −19.6% | down −19.3% |
| 5 Mar 2026 | 9 Mar 2026SEC Form 4 | 4 d | was grantednot a trade | PROCEPT BioRoboticsderivative | 32,576 shares | down −19.6% | down −19.3% |
| 5 Mar 2026 | 9 Mar 2026SEC Form 4 | 4 d | was grantednot a trade | PROCEPT BioRobotics | 47,462 shares | down −19.6% | down −19.3% |
| 19 Feb 2026 | 25 Feb 2026SEC Form 4 | 6 d | was grantednot a trade | PROCEPT BioRobotics | 3,532 shares | down −23.8% | down −26.8% |
| 19 Feb 2026 | 25 Feb 2026SEC Form 4 | 6 d | was grantednot a trade | PROCEPT BioRobotics | 3,532 shares | down −23.8% | down −26.8% |
| 18 Mar 2025 | 19 Mar 2025SEC Form 4 | 1 d | sold on the open market | PROCEPT BioRobotics | 733 shares | down −64.3% | down −64.7% |
| 6 Mar 2025 | 10 Mar 2025SEC Form 4 | 4 d | sold on the open market | PROCEPT BioRobotics | 3,662 shares | down −66.4% | down −64.6% |
| 3 Mar 2025 | 5 Mar 2025SEC Form 4 | 2 d | was grantednot a trade | PROCEPT BioRoboticsderivative | 14,388 shares | down −66.4% | down −67.8% |
| 3 Mar 2025 | 5 Mar 2025SEC Form 4 | 2 d | was grantednot a trade | PROCEPT BioRobotics | 16,290 shares | down −66.4% | down −67.8% |
| 15 Oct 2024 | 17 Oct 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 25,000 shares | down −71.7% | down −70.5% |
| 15 Oct 2024 | 17 Oct 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRobotics | 25,000 shares | down −71.7% | down −70.5% |
| 15 Oct 2024 | 17 Oct 2024SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 15,959 shares | down −71.7% | down −70.5% |
| 15 Oct 2024 | 17 Oct 2024SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 8,115 shares | down −71.7% | down −70.5% |
| 15 Oct 2024 | 17 Oct 2024SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 926 shares | down −71.7% | down −70.5% |
| 16 Sep 2024 | 18 Sep 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 15,917 shares | down −75.1% | down −75.4% |
| 16 Sep 2024 | 18 Sep 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 9,083 shares | down −75.1% | down −75.4% |
| 16 Sep 2024 | 18 Sep 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRobotics | 15,917 shares | down −75.1% | down −75.4% |
| 16 Sep 2024 | 18 Sep 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRobotics | 9,083 shares | down −75.1% | down −75.4% |
| 16 Sep 2024 | 18 Sep 2024SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 6,623 shares | down −75.1% | down −75.4% |
| 16 Sep 2024 | 18 Sep 2024SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 17,977 shares | down −75.1% | down −75.4% |
| 16 Sep 2024 | 18 Sep 2024SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 400 shares | down −75.1% | down −75.4% |
| 18 Mar 2024 | 20 Mar 2024SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 1,024 shares | down −58.2% | down −58.0% |
| 15 Mar 2024 | 18 Mar 2024SEC Form 4 | 3 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 36,010 shares | down −57.2% | down −58.2% |
| 15 Mar 2024 | 18 Mar 2024SEC Form 4 | 3 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 17,747 shares | down −57.2% | down −58.2% |
| 15 Mar 2024 | 18 Mar 2024SEC Form 4 | 3 d | exercised options overnot a trade | PROCEPT BioRobotics | 36,010 shares | down −57.2% | down −58.2% |
| 15 Mar 2024 | 18 Mar 2024SEC Form 4 | 3 d | exercised options overnot a trade | PROCEPT BioRobotics | 17,747 shares | down −57.2% | down −58.2% |
| 6 Mar 2024 | 19 Apr 2024SEC Form 4 | 44 d | was grantednot a trade | PROCEPT BioRoboticsderivative | 11,563 shares | down −56.8% | down −59.4% |
| 6 Mar 2024 | 19 Apr 2024SEC Form 4 | 44 d | was grantednot a trade | PROCEPT BioRobotics | 13,275 shares | down −56.8% | down −59.4% |
| 6 Mar 2024 | 7 Mar 2024SEC Form 4 | 1 d | was grantednot a trade | PROCEPT BioRoboticsderivative | 16,835 shares | down −56.8% | down −58.6% |
| 6 Mar 2024 | 7 Mar 2024SEC Form 4 | 1 d | was grantednot a trade | PROCEPT BioRobotics | 19,328 shares | down −56.8% | down −58.6% |
| 6 Mar 2024 | 7 Mar 2024SEC Form 4 | 1 d | sold on the open market | PROCEPT BioRobotics | 3,435 shares | down −56.8% | down −58.6% |
| 12 Feb 2024 | 13 Feb 2024SEC Form 4 | 1 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 22,349 shares | down −59.7% | down −58.2% |
| 12 Feb 2024 | 13 Feb 2024SEC Form 4 | 1 d | exercised options overnot a trade | PROCEPT BioRobotics | 22,349 shares | down −59.7% | down −58.2% |
| 12 Feb 2024 | 13 Feb 2024SEC Form 4 | 1 d | sold on the open market | PROCEPT BioRobotics | 22,349 shares | down −59.7% | down −58.2% |
| 9 Feb 2024 | 9 Feb 2024SEC Form 4 | 0 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 28,677 shares | down −59.2% | down −59.2% |
| 9 Feb 2024 | 9 Feb 2024SEC Form 4 | 0 d | exercised options overnot a trade | PROCEPT BioRobotics | 28,677 shares | down −59.2% | down −59.2% |
| 9 Feb 2024 | 9 Feb 2024SEC Form 4 | 0 d | sold on the open market | PROCEPT BioRobotics | 28,677 shares | down −59.2% | down −59.2% |
| 7 Feb 2024 | 9 Feb 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 904 shares | down −59.2% | down −59.2% |
| 7 Feb 2024 | 9 Feb 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRobotics | 904 shares | down −59.2% | down −59.2% |
| 7 Feb 2024 | 9 Feb 2024SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 904 shares | down −59.2% | down −59.2% |
| 9 Jan 2024 | 11 Jan 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 17,310 shares | down −58.1% | down −56.7% |
| 9 Jan 2024 | 11 Jan 2024SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRobotics | 17,310 shares | down −58.1% | down −56.7% |
| 9 Jan 2024 | 11 Jan 2024SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 17,310 shares | down −58.1% | down −56.7% |
| 13 Dec 2023 | 15 Dec 2023SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 71,465 shares | down −49.7% | down −53.1% |
| 13 Dec 2023 | 15 Dec 2023SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRobotics | 71,465 shares | down −49.7% | down −53.1% |
| 13 Dec 2023 | 15 Dec 2023SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 71,465 shares | down −49.7% | down −53.1% |
| 8 Dec 2023 | 8 Dec 2023SEC Form 4 | 0 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 6,888 shares | down −48.2% | down −48.2% |
| 8 Dec 2023 | 8 Dec 2023SEC Form 4 | 0 d | exercised options overnot a trade | PROCEPT BioRobotics | 6,888 shares | down −48.2% | down −48.2% |
| 8 Dec 2023 | 8 Dec 2023SEC Form 4 | 0 d | sold on the open market | PROCEPT BioRobotics | 6,888 shares | down −48.2% | down −48.2% |
| 7 Dec 2023 | 8 Dec 2023SEC Form 4 | 1 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 3,837 shares | down −49.0% | down −48.2% |
| 7 Dec 2023 | 8 Dec 2023SEC Form 4 | 1 d | exercised options overnot a trade | PROCEPT BioRobotics | 3,837 shares | down −49.0% | down −48.2% |
| 7 Dec 2023 | 8 Dec 2023SEC Form 4 | 1 d | sold on the open market | PROCEPT BioRobotics | 3,837 shares | down −49.0% | down −48.2% |
| 6 Dec 2023 | 8 Dec 2023SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRoboticsderivative | 4,360 shares | down −47.2% | down −48.2% |
| 6 Dec 2023 | 8 Dec 2023SEC Form 4 | 2 d | exercised options overnot a trade | PROCEPT BioRobotics | 4,360 shares | down −47.2% | down −48.2% |
| 6 Dec 2023 | 8 Dec 2023SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 4,360 shares | down −47.2% | down −48.2% |
| 15 Jun 2023 | 15 Jun 2023SEC Form 4 | 0 d | sold on the open market | PROCEPT BioRobotics | 22,631 shares | down −41.9% | down −41.9% |
| 16 Mar 2023 | 17 Mar 2023SEC Form 4 | 1 d | sold on the open market | PROCEPT BioRobotics | 706 shares | down −36.6% | down −35.3% |
| 8 Mar 2023 | 9 Mar 2023SEC Form 4 | 1 d | sold on the open market | PROCEPT BioRobotics | 22,046 shares | down −40.3% | down −37.6% |
| 7 Mar 2023 | 9 Mar 2023SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 7,136 shares | down −40.0% | down −37.6% |
| 7 Mar 2023 | 9 Mar 2023SEC Form 4 | 2 d | sold on the open market | PROCEPT BioRobotics | 818 shares | down −40.0% | down −37.6% |
| 16 Feb 2023 | 21 Feb 2023SEC Form 4 | 5 d | was grantednot a trade | PROCEPT BioRoboticsderivative | 47,732 shares | down −44.9% | down −43.3% |
| 16 Feb 2023 | 21 Feb 2023SEC Form 4 | 5 d | was grantednot a trade | PROCEPT BioRobotics | 26,315 shares | down −44.9% | down −43.3% |
| 31 Mar 2022 | 4 Apr 2022SEC Form 4 | 4 d | was grantednot a trade | PROCEPT BioRoboticsderivative | 16,020 shares | down −41.8% | down −41.9% |
| 31 Mar 2022 | 4 Apr 2022SEC Form 4 | 4 d | was grantednot a trade | PROCEPT BioRobotics | 7,914 shares | down −41.8% | down −41.9% |
| 3 Jul 2018 | 6 Jul 2018SEC Form 4 | 3 d | sold on the open market | Accuray | 14,641 shares | down −93.9% | down −93.9% |
| 3 Jul 2018 | 3 Jul 2018SEC Form 4 | 0 d | sold on the open market | Accuray | 14,265 shares | down −93.9% | down −93.9% |
| 3 Apr 2018 | 3 Apr 2018SEC Form 4 | 0 d | sold on the open market | Accuray | 2,997 shares | down −94.6% | down −94.6% |
| 1 Dec 2017 | 1 Dec 2017SEC Form 4 | 0 d | sold on the open market | Accuray | 3,830 shares | down −95.2% | down −95.2% |
| 30 Nov 2017 | 1 Dec 2017SEC Form 4 | 1 d | sold on the open market | Accuray | 3,324 shares | down −95.1% | down −95.2% |
| 1 Nov 2017 | 1 Nov 2017SEC Form 4 | 0 d | had shares withheld for taxnot a trade | Accuray | 1,487 shares | down −94.8% | down −94.8% |
| 3 Oct 2017 | 3 Oct 2017SEC Form 4 | 0 d | had shares withheld for taxnot a trade | Accuray | 6,185 shares | down −94.0% | down −94.0% |
| 29 Sep 2017 | 4 Oct 2017SEC Form 4 | 5 d | was grantednot a trade | Accuray | 45,500 shares | down −93.7% | down −94.0% |
| 29 Sep 2017 | 4 Oct 2017SEC Form 4 | 5 d | was grantednot a trade | Accurayderivative | 113,750 shares | down −93.7% | down −94.0% |
| 30 Jun 2017 | 3 Jul 2017SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Accuray | 15,502 shares | down −94.7% | down −94.6% |
| 3 Apr 2017 | 4 Apr 2017SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Accuray | 3,391 shares | down −94.7% | down −94.7% |
| 1 Dec 2016 | 2 Dec 2016SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Accuray | 3,449 shares | down −94.9% | down −94.9% |
| 30 Nov 2016 | 2 Dec 2016SEC Form 4 | 2 d | was grantednot a trade | Accuray | 38,200 shares | down −95.0% | down −94.9% |
| 30 Nov 2016 | 2 Dec 2016SEC Form 4 | 2 d | was grantednot a trade | Accurayderivative | 95,500 shares | down −95.0% | down −94.9% |
| 1 Nov 2016 | 2 Nov 2016SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Accuray | 1,393 shares | down −94.9% | down −94.9% |
| 3 Oct 2016 | 3 Oct 2016SEC Form 4 | 0 d | had shares withheld for taxnot a trade | Accuray | 6,331 shares | down −95.8% | down −95.8% |
| 11 Jul 2016 | 11 Jul 2016SEC Form 4 | 0 d | had shares withheld for taxnot a trade | Accuray | 4,864 shares | down −95.3% | down −95.3% |
| 8 Jul 2016 | 11 Jul 2016SEC Form 4 | 3 d | was grantednot a trade | Accuray | 12,345 shares | down −95.2% | down −95.3% |
| 30 Jun 2016 | 1 Jul 2016SEC Form 4 | 1 d | was grantednot a trade | Accuray | 125,000 shares | down −95.2% | down −95.1% |
| 31 Mar 2016 | 4 Apr 2016SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Accuray | 3,183 shares | down −95.7% | down −95.7% |
| 30 Nov 2015 | 2 Dec 2015SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Accuray | 3,289 shares | down −96.4% | down −96.5% |
| 30 Nov 2015 | 2 Dec 2015SEC Form 4 | 2 d | was grantednot a trade | Accuray | 2,500 shares | down −96.4% | down −96.5% |
| 2 Nov 2015 | 3 Nov 2015SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Accuray | 1,341 shares | down −96.4% | down −96.3% |
| 30 Sep 2015 | 30 Sep 2015SEC Form 4 | 0 d | was grantednot a trade | Accuray | 65,000 shares | down −95.0% | down −95.0% |
Both percentages are the stock’s move, not Kevin Waters’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 97 of the 97 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.